Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Renasant Corp
RNST
$3.96B
| $1.82M | ﹤0.01% |
69,614
+22,208
| +47% | +$615K |
|
|
CUTR
1902
DELISTED
Cutera, Inc.
CUTR
| $1.81M | ﹤0.01% |
119,401
+41,586
| +53% | +$788K |
|
1903
uniQure
QURE
$3.15B
| $1.81M | ﹤0.01% |
157,633
+90,148
| +134% | +$1.71M |
|
1904
Regenxbio
RGNX
$722M
| $1.8M | ﹤0.01% |
90,275
+23,527
| +35% | +$453K |
|
1905
Jackson Financial
JXN
$9.03B
| $1.8M | ﹤0.01% |
58,753
-156,654
| -73% | -$5.05M |
|
1906
Stagwell
STGW
$2.23B
| $1.8M | ﹤0.01% |
249,159
+132,298
| +113% | +$874K |
|
1907
Marten Transport
MRTN
$1.21B
| $1.79M | ﹤0.01% |
83,373
-8,559
| -9% | -$180K |
|
|
SEM
1908
DELISTED
Select Medical
SEM
| $1.79M | ﹤0.01% |
104,020
+5,435
| +6% | +$84.2K |
|
1909
Malibu Boats
MBUU
$562M
| $1.78M | ﹤0.01% |
30,408
-3,705
| -11% | -$208K |
|
1910
Clear Secure
YOU
$5.34B
| $1.78M | ﹤0.01% |
76,940
+33,311
| +76% | +$823K |
|
1911
Seres Therapeutics
MCRB
$47.9M
| $1.78M | ﹤0.01% |
18,545
+13,042
| +237% | +$1.42M |
|
1912
NMI Holdings
NMIH
$3.31B
| $1.77M | ﹤0.01% |
68,668
+1,884
| +3% | +$45.6K |
|
|
DICE
1913
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.76M | ﹤0.01% |
37,971
+16,655
| +78% | +$576K |
|
|
INBX
1914
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.76M | ﹤0.01% |
68,534
+3,873
| +6% | +$90.5K |
|
1915
Weatherford International
WFRD
$6.38B
| $1.76M | ﹤0.01% |
26,528
-9,297
| -26% | -$572K |
|
1916
Sprout Social
SPT
$492M
| $1.76M | ﹤0.01% |
38,075
+11,534
| +43% | +$549K |
|
1917
XPEL
XPEL
$1.31B
| $1.75M | ﹤0.01% |
20,804
+9,669
| +87% | +$715K |
|
1918
Carter's
CRI
$1.48B
| $1.74M | ﹤0.01% |
24,025
+17,519
| +269% | +$1.18M |
|
1919
NBT Bancorp
NBTB
$2.75B
| $1.74M | ﹤0.01% |
54,618
+14,770
| +37% | +$494K |
|
1920
Amphastar Pharmaceuticals
AMPH
$873M
| $1.74M | ﹤0.01% |
30,257
-11,057
| -27% | -$490K |
|
1921
Itaú Unibanco
ITUB
$90.2B
| $1.73M | ﹤0.01% |
332,174
-32,684
| -9% | -$154K |
|
|
JOYY
1922
JOYY Inc
JOYY
$3.77B
| $1.73M | ﹤0.01% |
56,238
-126,727
| -69% | -$3.71M |
|
|
DAWN
1923
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.72M | ﹤0.01% |
144,403
+70,834
| +96% | +$925K |
|
1924
IDEAYA Biosciences
IDYA
$3.49B
| $1.72M | ﹤0.01% |
73,277
+11,020
| +18% | +$227K |
|
1925
Nu Skin
NUS
$252M
| $1.72M | ﹤0.01% |
51,805
+22,098
| +74% | +$814K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.